Journal of Autism and Developmental Disorders

, Volume 26, Issue 4, pp 439–452

Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics

  • Sudhir Gupta
  • Sudeepta Aggarwal
  • Cathy Heads
Brief Reports


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Psychiatric Association. (1987).Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.Google Scholar
  2. Chapel, H., & Haeney, M. (Eds.). (1993).Essentials of clinical immunology (pp. 57–58). London: Blackwell.Google Scholar
  3. Donaghy, M., Mills, K. R., Boniface, S. J., Simmons, J., Wright, I., Gregson, N., & Jacobs, J. (1994). Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.Journal of Neurology, Neurosurgery and Psychiatry, 57: 778–783.Google Scholar
  4. Dwyer, J. M. (1992). Manipulating the immune system with immune globulin.New England Journal of Medicine, 326, 4104–4109.Google Scholar
  5. Erkeller-Yuksel, F. M., Deneys, V., Yuksel, B., Hannet, I., Hulstaert, F., Hamilton, C., Mackinnon, H., Stokes, L. T., Munhyeshuli, V., Vanlangendonck, F., De Bruyere, M., Bach, B. A., & Lydyard, P. M. (1992). Age-related changes in human blood lymphocyte subpopulations.Journal of Pediatrics, 120, 216–222.Google Scholar
  6. Gillberg, C., & Coleman, M. (Eds.). (1992).The biology of the autistic syndromes (2nd ed., pp. 218–225). London: Mac Keith Press.Google Scholar
  7. Gupta, S. (1986). Current and potential future uses of intravenous gamma globulin in the treatment of autoimmune disorders.Immunology & Allergy Practice, 8, 370–377.Google Scholar
  8. Herberman, R. B., & Ortaldo, J. R. (1981). Natural killer cells: Their role in defense against disease.Science, 214, 24–30.Google Scholar
  9. Kanner, L. (1943). Autistic disturbances of affective contact.Nervous Child, 2, 2217–250.Google Scholar
  10. Koski, C. L. (1987). Complement fixing anti-peripheral myelin antibodies and C9 neoantigens in serum of patients with Guillain-Barre syndrome: Quantitation, kinetics and clinical correlation.Annals New York Academy of Science, 505, 319–325.Google Scholar
  11. Menage, P., Thibault, G., Barthelemy, C., Lelord, G., & Bardos, P. (1992). CD4+CD45RA+ T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment.Brain Dysfunction, 5, 326–333.Google Scholar
  12. Mobini, N., Sarela, A., & Ahmed, A. R. (1995). Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.Annals of Allergy, Asthma & Immunology, 74, 119–132.Google Scholar
  13. Romagnani, S. (1995). Biology of TH1 and TH2 cells.Journal of Clinical Immunology, 15, 121–129.Google Scholar
  14. Schwartz, S. A. (1990). Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.Journal of Clinical Immunology, 10, 81–89.Google Scholar
  15. Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior.Brain, Behavior & Immunity, 7, 97–103.Google Scholar
  16. Stubbs, E. G. (1976). Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination.Journal of Autism and Childhood Schizophrenia, 6, 169–214.Google Scholar
  17. Stubbs, E. G., Crawford, M. L., Burger, D. R., & Vandebork, A. A. (1977). Depressed lymphocyte responsiveness in autistic children.Journal of Autism and Childhood Schizophrenia, 7, 49–55.Google Scholar
  18. Van der Meche, F. G. A., & Schmitz, P. I. M. (1992). A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barre syndrome.New England Journal of Medicine, 326, 1123–1129.Google Scholar
  19. Warren, R. P., Foster, A., & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism.Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333–335.Google Scholar
  20. Warren, R. P., Foster, A., Margaretten, N. C., & Pace, N. C. (1986). Immune abnormalities in patients with autism.Journal of Autism and Developmental Disorders, 16, 189–197.Google Scholar
  21. Warren, R. P., Yonk, L. I., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990). Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.Immunological Investigation, 19, 245–251.Google Scholar
  22. Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., & White, E. (1991). Increased frequency of the null allele at the complement C4b locus in autism.Clinical and Experimental Immunology, 83, 438–440.Google Scholar
  23. Weizman, A., Weizman, R., Szekely, G. A., Wijsenbeek, H., & Livni, E. (1982). Abnormal immune response to brain tissue antigen in the syndrome of autism.American Journal of Psychiatry, 139, 1462–1465.Google Scholar
  24. Yman, L. (1991). Standardization of IgE antibody assays.Journal of International Federation of Clinical Chemistry, 3, 198–203.Google Scholar
  25. Yonk, L. J., Warren, R. P., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990). CD4+ helper T cell depression in autism.Immunology Letters, 25, 314–346.Google Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Sudhir Gupta
    • 1
  • Sudeepta Aggarwal
    • 1
  • Cathy Heads
    • 1
  1. 1.Division of Basic and Clinical ImmunologyUniversity of CaliforniaIrvine
  2. 2.Medical Sciences I, C-240University of CaliforniaIrvine

Personalised recommendations